Knowledge Translation in OncologyThe Bumpy Ride From Bench to Bedside

被引:7
|
作者
Morgan, Sarah [1 ,2 ]
Hanna, Jessica [1 ,2 ]
Yousef, George M. [1 ,2 ]
机构
[1] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[2] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON, Canada
关键词
Knowledge translation; Precision medicine; Molecular pathology; Personalized medicine; PRIMARY-CARE; GENOMIC MEDICINE; DECISION-SUPPORT; GENETIC SERVICES; RISK-ASSESSMENT; CANCER; INTEGRATION; PHYSICIANS;
D O I
10.1093/ajcp/aqz099
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: Knowledge translation (KT) is the dynamic process of mobilizing best-practice evidence to guide health care decisions. Methods: Using a PubMed search, challenges were identified and milestones defined. Results: Substantial challenges exist in integrating discoveries into patient care, including technical limitations related to genomic testing like turnaround time, standardization, reproducibility, and results interpretation. Other challenges include lack of proper training in genetic counseling for health care providers, clarity of scientific evidence, and ethical, legal and social considerations. In addition, most health care systems lack accessibility to genetic testing services. Moving forward, KT should be addressed at three main frontiers. The first is patients centered for proper understanding and decision making; the second is directed toward health care professionals, including clinical decision support and clarity of roles; and the third addresses resources of health care systems. Conclusions: Implementing KT requires developing strategies to enhance awareness and promote behavioral changes congruent with research evidence, designing a systematic approach by health care providers and stakeholders to achieve patient-centered care.
引用
收藏
页码:5 / 13
页数:9
相关论文
共 50 条
  • [41] Platelets in chronic liver disease, from bench to bedside
    Ramadori, Pierluigi
    Klag, Thomas
    Malek, Nisar Peter
    Heikenwalder, Mathias
    JHEP REPORTS, 2019, 1 (06) : 448 - 459
  • [42] From Bench to Every Bedside: Improving the Adoption of Evidence-Based Practices
    Rodwin, Benjamin A.
    Merchant, Naseema B.
    SOUTHERN MEDICAL JOURNAL, 2020, 113 (11) : 538 - 540
  • [43] Angiogenesis in gastrointestinal stromal tumors: From bench to bedside
    Papadakos, Stavros P.
    Tsagkaris, Christos
    Papadakis, Marios
    Papazoglou, Andreas S.
    Moysidis, Dimitrios, V
    Zografos, Constantinos G.
    Theocharis, Stamatios
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 14 (08) : 1469 - 1477
  • [44] Modeling human osteosarcoma in the mouse: From bedside to bench
    Janeway, Katherine A.
    Walkley, Carl R.
    BONE, 2010, 47 (05) : 859 - 865
  • [45] New Avenues in Radiotherapy of Glioblastoma: from Bench to Bedside
    Gouazo-Andersson, Valorie
    Cohen-Jonathan Moyal, Elizabeth
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2020, 22 (12)
  • [46] The role of Dickkopf family in cancers: from Bench to Bedside
    Shao, You-Cheng
    Wei, Yan
    Liu, Jin-Fang
    Xu, Xiao-Yan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2017, 7 (09): : 1754 - 1768
  • [47] Dashboard Systems: Implementing Pharmacometrics from Bench to Bedside
    Mould, Diane R.
    Upton, Richard N.
    Wojciechowski, Jessica
    AAPS JOURNAL, 2014, 16 (05): : 925 - 937
  • [48] Organoid based personalized medicine: from bench to bedside
    Li Y.
    Tang P.
    Cai S.
    Peng J.
    Hua G.
    Cell Regeneration, 9 (1)
  • [49] miRNA Multiplayers in glioma. From bench to bedside
    Rolle, Katarzyna
    ACTA BIOCHIMICA POLONICA, 2015, 62 (03) : 353 - 365
  • [50] Patient engagement in melanoma research: from bench to bedside
    Tivey, Ann
    Huddar, Prerana
    Shotton, Rohan
    Cheese, Imogen
    Daniels, Susanna
    Lorigan, Paul
    J Lee, Rebecca
    FUTURE ONCOLOGY, 2021, 17 (28) : 3705 - 3716